Screener
Xenon Pharmaceuticals XENE Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Xenon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Xenon Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338244
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Current liabilities: | ||
| Accounts payable and accrued liabilities (note 7) | $43,671 | $40,260 |
| Operating lease liability (note 6) | 1,338 | 1,532 |
| Total current liabilities | 45,009 | 41,792 |
| Operating lease liability, long-term (note 6) | 5,080 | 6,412 |
| Other liabilities, long-term | 3,287 | 3,199 |
| Total liabilities | $53,376 | $51,403 |
| Shareholders’ equity: |
Item 1. Financial Statements
FAQ
- What is Xenon Pharmaceuticals's total current liabilities?
- Xenon Pharmaceuticals (XENE) reported total current liabilities of $45.01M in Q2 2026.
- How has Xenon Pharmaceuticals's total current liabilities changed year-over-year?
- Xenon Pharmaceuticals's total current liabilities increased by 36.2% year-over-year, from $33.05M to $45.01M.
- What is the long-term trend for Xenon Pharmaceuticals's total current liabilities?
- Over 5 years (2020 to 2025), Xenon Pharmaceuticals's total current liabilities has grown at a 23.1% compound annual growth rate (CAGR), from $14.78M to $41.79M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Xenon Pharmaceuticals's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude